Plain-English translation of NCT07756476 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new approach to giving fluids to patients with acute pancreatitis (sudden, severe pancreas inflammation). Instead of using a one-size-fits-all formula based on body weight, researchers want to see if tailoring fluids to how your body responds—measured by checking your heart's stroke volume—leads to better outcomes and prevents fluid overload.
Recent research showed that giving large amounts of fluid to pancreatitis patients didn't improve their recovery and actually increased the risk of dangerous fluid buildup. This trial exists to test whether a personalized approach—adjusting fluids based on your individual body's response—could be safer and more effective.
You likely qualify if…
You likely don't qualify if…
You would be randomly assigned to one of two groups: one group receiving personalized fluids guided by measurements of your heart's stroke volume (including a simple leg raise test), and another group receiving fluids based on standard weight-based guidelines. Throughout the trial, the research team would monitor your response to treatment with exams and measurements to compare which approach works better and is safer for acute pancreatitis.
AI-generated summary from trial data · Aug 24, 2026 · Not medical advice
United States